全催化疗法:一种非毒性疾病治疗模式
1Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|September 4, 2025
概括
泛催化疗法 (PCT) 提供一种无毒的治疗方法,通过精确地将催化剂输送到疾病部位. 这种方法可以激活现场反应, 针对病态环境, 同时保持身体生态, 尽量减少副作用, 以获得更安全,更有效的疾病管理.
科学领域:
- 生物医学工程
- 催化科学
- 生态医学
背景情况:
- 传统的疾病治疗通常涉及有毒药物或侵袭性手术,
- 需要一种非有毒的治疗方法来维持身体的自然生态平衡.
研究的目的:
- 将泛催化药 (PM) 引入并定义为一种新的,无毒的治疗范式.
- 阐明PM的原理和机制,强调其与人体生态的融合.
- 突出PM的潜力,以提高安全性,实现针对性的疾病治疗.
主要方法:
- 催化剂制备 (P):为目标输送开发特定的催化剂.
- 生物效应激活 (A):在疾病部位激活催化剂的策略.
- 多功能性疾病的无毒治疗 (N):对病态微环境的催化反应的应用.
主要成果:
- 微粒能够在疾病部位进行精确的触媒反应, 针对癌症和炎症等病理状况.
- 该方法通过仅在特定的病理微环境内激活催化剂来最大限度地降低目标外毒性.
- 有效地保持正常组织平衡和身体的整体生态平衡.
结论:
- 泛催化疗法 (PCT) 代表了疾病治疗的范式转变,整合了生态原则以提高特异性和安全性.
- PCT为开发具有减少副作用的无毒疗法提供了一种革命性的方向.
- 这种方法对未来的医疗应用具有重大前景,特别是在治疗慢性和复杂疾病方面.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Chronic Pancreatitis II: Collaborative Care
127
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
127
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Antidotes
755
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
755


